Profile: Spherix Inc (SPEX.OQ)
7 Mar 2014
Spherix Incorporated (Spherix), incorporated on May 1, 1992, is a scientific research company. The Company is engaged in developing biopharmaceutical products and providing technical and regulatory consulting services to food, consumer products and pharmaceutical companies. The Company operates in two segments: Biospherics Incorporated (Biospherics), the Company's biotechnology research and development business, and Health Sciences, a technical and regulatory consulting business. The Company has created two wholly owned subsidiaries, Biospherics Incorporated and Spherix Consulting, Inc. (Spherix Consulting), for its two operating segments. The Company's Health Sciences contracts are in the name of Spherix Consulting, and the Company's patents are in the name of Biospherics Incorporated. Spherix provides management, strategic guidance, business development, marketing and other services to its subsidiaries. In September 2013, Spherix Incorporated closed on the acquisition of North South Holdings Inc.
The Company focuses its studies on treating high triglycerides and other dyslipidemias with a combination of D-tagatose and SPX-106, a licensed drug compound, which combination is referred to as SPX-106T. Spherix Consulting provides scientific and strategic support for suppliers, manufacturers, distributors and retailers of conventional foods, biotechnology-derived foods, medical foods, infant formulas, food ingredients, dietary supplements, food contact substances, pharmaceuticals, medical devices, consumer products, and industrial chemicals and pesticides. Biospherics has also completed a global Phase III clinical trial investigating the use of D-Tagatose, a stereoisomer of fructose, as a treatment for glycemic control in patients with Type 2 diabetes.
The Company's Health Sciences business provides technical and regulatory consulting services to biotechnology and pharmaceutical companies, as well as providing technical support for its research and development activities. During the year ended December 31, 2011, Health Sciences provided services to 20 companies. The projects range from safety analyses of food ingredients to safety analyses of pharmaceutical manufacturing and dispensing equipment. Health Sciences is also monitoring and directing the clinical trials for Biospherics.
#503, 6430 ROCKLEDGE DRIVE
BETHESDA MD 20817